New functionality allows veterinarians to leverage their existing Covetrus software and services to maintain continuity of care through COVID-19 and beyond
PORTLAND, Maine–(BUSINESS WIRE)–Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it is embedding secure video teleconferencing capabilities across the company’s global suite of practice information management systems (PIMS), client communications, and prescription management solutions. This new functionality provides a seamless and easily accessible way for veterinarians to service their clients and patients remotely using their existing Covetrus technology solutions.
“It is inspiring to see the veterinary community in action as they work even harder to support and provide care to their clients during the COVID-19 pandemic. To further help, we directed our efforts into fast-tracking a product extension for telemedicine that we expect to be even more impactful in the current environment,” said Georgia Wraight, president, Covetrus Global Technology Solutions. “By making this functionality available across our suite of technology solutions, those that our customers already know and use daily in their practice, we hope to ease and enhance the ways in which veterinarians are able to maintain care with their clients throughout this crisis … and after.”
To support the veterinary community during the COVID-19 pandemic, all users of Covetrus technology platforms will have free access to video conferencing capabilities, until further notice. Starting today, users of the Rapport™ client communications product have access to video conferencing, further building on its two-way, omni-channel messaging via email, text, and now video. In the coming weeks, Covetrus will also launch these secure video capabilities directly into its PIMS, including AVImark®, eVetPractice® and ImproMed®, as well as its prescription management platform. International platforms, including RxWorks in Australia and RoboVet in the U.K., will also gain this advanced functionality.
“The Rapport client communication system is already a critical tool for us to stay in touch with our clients about their appointments and care,” said Alinda Higgins, CVT, manager, East Lake Hospital for Animals, Ltd. “With video conferencing, we’ll not only be able to maintain communication, but make it easier for us to actively deliver care for our patients. It’s the next best thing to having the patient physically in front of you. During times when everything seems more complex, Covetrus has come through to make patient care safe and more convenient for our clients and their pets.”
Covetrus will offer user training for this new capability along with their series of educational webinars aimed at navigating the COVID-19 pandemic. For more information about the new video capability now available in Rapport, and to keep updated on the timing of upcoming releases into the Covetrus suite of technology, go to https://get.covetrus.com/rapport-telemedicine.
This week’s webinar features VMX Speaker of the Year, Eric Garcia in a session titled “Navigating Client Communications Amid COVID-19”. In this one-hour webinar, Garcia will discuss how to maintain and build connections with clients during this challenging time. The webinar will take place Thursday, April 16th at 12:00 p.m. EDT. To register go to: rxmanagement.covetrus.com/webinars.
About Covetrus
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. Learn more at covetrus.com.
Forward-Looking Statements
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.
Contacts
Nicholas Jansen | Investor Relations
nicholas.jansen@covetrus.com | (207) 550-8106
Kiní Schoop | Public Relations
kini.schoop@covetrus.com | (207) 550-8018
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…